DanaherDHR
Life science tools · NYSE · USA
$217.46
Down 0.5% todayClose
Down 4.6% this year but +10.8% since June 26, ahead of the life science sector at +10.7%. Danaher supplies 3 mapped companies.
Supply chain
3 customersAbout Danaher
Cytiva supplies the equipment biologics are made with; Cepheid runs molecular diagnostics. Danaher owns both, along with a wider set of life science instruments.
Theme exposure
Products
- Bioprocessing (Cytiva)
- Molecular diagnostics (Cepheid)
- Life science instruments
Competitors
- Thermo Fisher
- Sartorius
- Agilent
Risks
- Cyclical bioprocessing demand
- Customer inventory normalisation
Same segment: Life science tools
Instruments, reagents and equipment for research, development and production. Segment 5 of 8 in the Medicine, pharma & life science value chain.
Compare DHR
Side by side with the largest companies in the same segment.
See where Danaher sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.
Open the Life science value chain →